[{"NetIncomeLoss_1_Q2_USD":9276032.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2195515.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":1.56,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":1014874.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-12198.0,"Depreciation_2_Q2_USD":30169.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":962720.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":136489.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":20119.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":2994228.0,"DividendsCommonStockCash_2_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":45434765.0,"AccruedVacationCurrent_0_Q2_USD":79820.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q2_USD":9592.0,"CommonStockSharesIssued_0_Q2_shares":40588004.0,"Assets_0_Q2_USD":45715695.0,"ShareBasedCompensation_2_Q2_USD":635808.0,"ShareBasedCompensation_1_Q2_USD":308341.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":114714.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":0.43,"GeneralAndAdministrativeExpense_2_Q2_USD":4481406.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":0.76,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":2.02,"OperatingLeaseLiability_0_Q2_USD":121008.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":600000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":5377614.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3548572.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":1.8,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":129175.0,"AccruedBonusesCurrent_0_Q2_USD":318591.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":40747960.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":40905288.0,"PrepaidExpenseCurrent_0_Q2_USD":307400.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.6936,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.7482,"CommonStockValue_0_Q2_USD":4059.0,"DepositsAssetsNoncurrent_0_Q2_USD":20000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":-491704.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":1452470.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_2_Q2_USD":-238797.0,"OtherAssetsCurrent_0_Q2_USD":263081.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0053,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0038,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":44864284.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":9955.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":179474553.0,"Liabilities_0_Q2_USD":3115236.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":8167.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":15000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":2295314.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":308341.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6351946.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":40588004.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":40588004.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":69685.0,"LiabilitiesCurrent_0_Q2_USD":3105281.0,"AccountsPayableCurrent_0_Q2_USD":622658.0,"NonoperatingIncomeExpense_2_Q2_USD":216389.0,"NonoperatingIncomeExpense_1_Q2_USD":20119.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":29913.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.1328,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":678430.0,"LiabilityForUncertainTaxPositionsCurrent_0_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":44864284.0,"RestructuringReserveCurrent_0_Q2_USD":278846.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"OperatingLeasePayments_2_Q2_USD":58290.0,"OperatingLeasePayments_1_Q2_USD":29145.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":336444.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":146216.0,"NetIncomeLoss_2_Q2_USD":5357369.0,"CommonStockSharesOutstanding_0_Q2_shares":40588004.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":6339748.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":15000000.0,"OperatingIncomeLoss_2_Q2_USD":5140980.0,"OperatingIncomeLoss_1_Q2_USD":9255913.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.71,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"OperatingLeaseCost_2_Q2_USD":56715.0,"OperatingLeaseCost_1_Q2_USD":28357.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":45715695.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":59490.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":111053.0,"OperatingExpenses_2_Q2_USD":9859020.0,"OperatingExpenses_1_Q2_USD":5744087.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.13,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.23,"ProfitLoss_2_Q2_USD":5357369.0,"StockholdersEquity_0_Q2_USD":42600459.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":12198.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4846100.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2550786.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-136878153.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":2108948.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":355602.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200812"}]